GenMark Diagnostics (GNMK) Reports In-Line Q3 EPS

GenMark Diagnostics (NASDAQ: GNMK) reported Q3 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.28 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
• nCino, Inc. (NCNO) Reports Q2 EPS of $0.05, Offers Guidance
• Semtech (SMTC) Tops Q2 EPS by 10c, Beats on Revenue; Offers Q3 Guidance